Opendata, web and dolomites

BPET

The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BPET project word cloud

Explore the words cloud of the BPET project. It provides you a very rough idea of what is the project "BPET" about.

patients    market    diagnostic    brain    capital    expensive    5m    detect    people    start    2030    bpet       5x    treatments    total    clinical    hood    grow    diseases    programs    enabled    modifying    global    follow    larger    diverse    efficient    tool    complete    drying    tomography    launch    diminish    positrigo    innovative    cohort    body    lasting    alzheimer    populations    tools    treatment    specially    industrial    emission    2018    400    accelerate    roi    parallel    instead    ad    neurodegenerative    healthcare    tri    first    10x    size    marking    scanner    validation    diagnosis    shown    swiss    founded    ce    sold    stage    tested    scanners    suffering    modal    capacity    company    millions    76    laboratory    positron    doctors    acquire    pave    uses    hospitals    accurate    prototype    requested    burden    epidemic    profits    hallmarks    preliminary    live    mobile    performance    pet    scanning    alternative    near    detection    expenses    boosting    drug    filling    room   

Project "BPET" data sheet

The following table provides information about the project.

Coordinator
POSITRIGO AG 

Organization address
address: OTTO-STERN-WEG 5
city: ZURICH
postcode: 8093
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.positrigo.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POSITRIGO AG CH (ZURICH) coordinator 50˙000.00

Map

 Project objective

Alzheimer’s (AD) is a global epidemic with 50 M people suffering it and 76 M expected by 2030 (related costs near $1 Tri in 2018). To diminish its burden, an early detection is crucial, specially when modifying treatments become available. The most accurate method to measure AD hallmarks is positron emission tomography (PET), but current PET scanners are multi-modal, whole-body, room-filling, expensive to acquire (€1-5 M) and not commonly used. Thus, there is still a need for more efficient diagnostic tools to detect AD at an early stage to adopt the best live-lasting treatment. Positrigo is a Swiss start-up, founded with the goal of provide an efficient PET tool for the early diagnosis of neurodegenerative diseases. Our technology has enabled us to develop a first prototype of BPET which has been preliminary tested in the laboratory with high performance. BPET is a dedicated mobile brain scanner with the size of a drying hood, 10x less capital (€400 k instead of millions) and 5x less operational expenses than current scanners. It will greatly improve early diagnosis of AD, facilitate its treatment follow-up and contribute to accelerate drug development programs, with a 10x increase in scanning capacity. BPET can be sold to hospitals and clinical research organizations, tailored to the needs of patients and doctors, and it can enable new case uses of brain PET (e.g many scanners used in parallel, wider populations, in larger cohort research studies). Diverse hospitals have shown their interest in BPET and their support for its complete development for its potential applications and impact. To launch BPET in the healthcare market we need its CE marking, clinical validation and industrial adaptation, so a total of €2.5M for phase 2 will be requested. BPET project will pave the way for our company to be established as an innovative alternative in scanner-based diagnosis, boosting our company to grow and reach around €30 M profits and a ROI of 7.4 after 5 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BPET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BPET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More